Anti-Ageing Treatment Market By Treatment Type (Injectable, Topical, Energy-Based Devices, Surgical), Target Area (Face, Neck, Hands, Body), End-User (Dermatology Clinics, Hospitals, Spas & Beauty Centers, Homecare), and Region; Global Insights & Forecast (2023 ? 2030)

As per Intent Market Research, the Anti-Ageing Treatment Market was valued at USD 41.6 Billion in 2024-e and will surpass USD 70.9 Billion by 2030; growing at a CAGR of 7.9% during 2025-2030.

The Anti-Ageing Treatment market has gained significant traction as the demand for aesthetic enhancements and preventive ageing solutions continues to rise globally. With advancements in technology and increasing consumer awareness, the market is expanding across various treatment types, target areas, and end-user categories. Innovations in injectables, topical products, and energy-based devices are meeting the needs of a diverse demographic, from those seeking subtle rejuvenation to individuals requiring comprehensive surgical procedures.

Injectable Segment is Largest Owing to Popularity of Minimally Invasive Procedures

The Injectable segment, which includes botulinum toxin and dermal fillers, is the largest in the Anti-Ageing Treatment market. This dominance is attributed to the growing preference for minimally invasive procedures that offer immediate results with minimal downtime. Botulinum toxin is widely used for reducing dynamic wrinkles, while dermal fillers effectively address volume loss and fine lines. The appeal of injectables lies in their ability to provide a natural, youthful appearance without the risks associated with surgical procedures.

Additionally, the expanding applications of injectables, such as in lip augmentation and jawline contouring, are broadening their consumer base. Increased awareness and the availability of skilled practitioners are further fueling the demand for injectable treatments worldwide.

Energy-Based Devices Segment is Fastest Growing Due to Technological Advancements

The Energy-Based Devices segment, comprising laser, radiofrequency, and ultrasound technologies, is the fastest-growing segment in the market. These devices provide non-invasive or minimally invasive solutions for skin tightening, wrinkle reduction, and overall rejuvenation. Advances in technology have made treatments more effective, safer, and accessible, contributing to their rapid adoption.

Energy-based treatments also offer long-lasting results and are increasingly used as preventive solutions for ageing. As more consumers seek alternatives to surgical options, this segment is expected to witness sustained growth, especially in regions where aesthetic technology adoption is on the rise.

Face Target Area is Largest Owing to High Consumer Demand

The Face segment is the largest target area within the Anti-Ageing Treatment market, driven by consumer focus on facial aesthetics and the visibility of ageing signs in this area. Treatments targeting wrinkles, fine lines, and skin laxity on the face are highly sought after, making this category a priority for both consumers and service providers.

Advanced technologies and treatments, including injectables, laser resurfacing, and facelifts, cater specifically to facial rejuvenation. The prominence of facial aesthetics in personal confidence and social interactions ensures sustained demand for solutions targeting this area.

Homecare Segment is Fastest Growing Owing to Convenience and Cost-Effectiveness

The Homecare segment is the fastest-growing end-user category as consumers increasingly prefer at-home anti-ageing solutions for convenience and cost-effectiveness. Devices and products designed for personal use, such as LED masks, microcurrent devices, and high-performance skincare formulations, are gaining traction.

The COVID-19 pandemic has further accelerated this trend, with consumers opting for at-home treatments due to restrictions on clinic visits. The growth of e-commerce platforms and advancements in user-friendly devices are also driving the expansion of this segment.

Asia-Pacific Region is Fastest Growing Due to Rising Aesthetic Awareness

Asia-Pacific is the fastest-growing region in the Anti-Ageing Treatment market, supported by rising consumer awareness, increasing disposable incomes, and a strong emphasis on beauty and skincare. Countries like China, Japan, and South Korea are at the forefront of this growth, with their established cosmetic industries and early adoption of innovative treatments.

The region’s cultural focus on youthful appearances and the influence of media and beauty standards contribute to the demand for anti-ageing solutions. Additionally, a growing network of aesthetic clinics and trained professionals further supports market expansion.

Competitive Landscape and Leading Companies

The Anti-Ageing Treatment market is highly competitive, with leading companies such as Allergan Aesthetics (AbbVie), L'Oréal, and Procter & Gamble driving innovation through advanced formulations and technologies. Companies are focusing on mergers, acquisitions, and collaborations to expand their product portfolios and geographical reach.

The competitive landscape is marked by continuous advancements in treatment options, such as the development of more effective injectables and energy-based devices. Additionally, sustainability and safety in product development are becoming key differentiators, as companies aim to meet the evolving expectations of a well-informed consumer base

Recent Developments:

• Allergan Aesthetics Expands Portfolio with FDA Approval for New Injectable Wrinkle Treatment
• L'Oréal Partners with Biotechnology Firms to Launch Advanced Anti-Ageing Serums
• Procter & Gamble Acquires Skincare Brand to Enhance Anti-Ageing Product Offerings
• Cynosure Introduces Next-Generation Laser Technology for Non-Invasive Skin Tightening
• Hologic Inc. Gains Regulatory Approval for New Radiofrequency Device in Aesthetic Applications

List of Leading Companies:

• Allergan Aesthetics (AbbVie)
• L'Oréal
• Procter & Gamble (P&G)
• Johnson & Johnson
• Unilever
• Estée Lauder Companies Inc.
• Cynosure
• Beiersdorf AG
• Shiseido Company
• Hologic Inc.
• Candela Medical
• Pierre Fabre Laboratories
• Revance Therapeutics
• Amorepacific Corporation
• Lumenis Ltd.

Report Scope: